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INTRODUCTION
Southern tick associated rash illness (also known
as STARI) has been recognised in the southern
and south-central regions of the United States
[1,2]. The disease is characterised by a migrating
erythematous rash, often with central clearing,
that occurs 2–15 days following a tick bite.
Lesions are usually solitary, although multiple
lesions may develop. The aetiology of STARI has
been investigated for nearly a decade, yet no clear
microorganism has been identiﬁed as the causa-
tive agent of this illness. Several features of this
illness are compatible with an infectious agent.
When a preceding tick bite is recognised, it is
always from the lone star tick (Amblyomma amer-
icanum). Many patients show improvement coin-
cident with treatment with a tetracycline
antibiotic. Spotted fever group rickettsiae had
been investigated as a cause of erythema migrans
in early Lyme disease work, but the lack of
positive results may have made this avenue less
appealing to researchers looking at STARI cases.
Because it has been shown that the spotted fever
group rickettsia ‘R. amblyommii’ can be found in a
high proportion of questing A. americanum [3], it is
possible that this agent, thus far not shown to be
pathogenic, might play a role in the evolution of
this disease syndrome. To that end, we examined
paired acute and convalescent phase serum sam-
ples from patients with STARI to see if any
reactivity or seroconversions to ‘R. amblyommii’ or
several other rickettsial agents could be demon-
strated.
METHODS
Paired acute and convalescent (1–3 months) serum samples
from eight well-characterised patients with rash following a
tick bite in Missouri were obtained under a protocol approved
by the Institutional Review Board of New York Medical
College (Valhalla, NY). These samples had previously been
tested in serologic and molecular assays for borreliae [2].
To assess possible exposure to spotted fever group rickett-
sial infection, the samples were evaluated in indirect immu-
noﬂuorescence assays using FITC-labelled rabbit anti-human
immunoglobulin IgG (gamma chain speciﬁc) conjugate. The
assays used the following species and strains of spotted fever
group rickettsiae: R. rickettsii Shelia Smith strain, R. parkeri
Maculatum 20 strain, R. akari Hartford strain, and ‘R. am-
blyommii’ Darkwater strain. All SFGR rickettsial antigens were
cultivated in Vero cells or chicken yolk sac. The samples were
also tested in an IFA against Ehrlichia chaffeensis (Arkansas
strain) antigens prepared similarly from cultures grown in
DH82 canine monocytic cell monolayers, and against typhus
group rickettsiae (R. prowazekii Breinl strain, and R. typhi
Wilmington strain) grown in chicken yolk sac.
Antigen slides were prepared by dotting antigen suspen-
sions onto templated glass slides, allowing them to air-dry,
and then ﬁxing them with acetone for 10 min at room
temperature. Slides were stored at )70C until used in the
assay.
RESULTS
Three of the eight patients had IgG antibodies
reactive with rickettsial antigens in one or both
serum samples. One had a low acute titre
(IFA = 64) to E. chaffeensis and one had low titres
(IFA = 64) to R. rickettsii, R. parkeri and R. akari,
but not to ‘R. amblyommii’. We did not observe
any change in antibody level in the samples taken
1–3 months later in either patient. Only one of the
eight patients showed moderate seroconversion
(rising from <16 to 128) to the four spotted fever
group rickettsiae tested by IFA.
DISCUSSION
The aetiology of STARI remains elusive. Previous
efforts have not been successful in establishing
any microorganism or virus as a cause [1,2,4].
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Although this was a small series, our results do
not suggest that STARI is likely to have a
rickettsial aetiology. In a single case, we did show
seroconversion to several members of the SFGR,
but the speciﬁc aetiology cannot be determined by
serology due to cross-reactive epitopes. Molecular
assay of the corresponding skin biopsies is
planned.
The role of ‘R. amblyommii’ in mild human
illness remains speculative as speciﬁc antigens or
nucleic acids have not been demonstrated from
human specimens. In a recent report, an
‘R. amblyommii’ -infected tick was removed from
a patient from North Carolina who subsequently
developed a macular rash [5]. However, no
clinical specimen was collected for serologic or
molecular analysis. The infection rate of this
organism in A. americanum is often high and this
tick is an aggressive human biter, so exposure is
likely to occur. Future investigations should
closely examine the possibility of transmission
to humans and any development of disease.
It is plausible that exposure to ‘R. amblyommii’
or other members of the SFG may induce anti-
bodies cross-reactive in serologic assays using
R. rickettsii antigens. Mild cases of illness due to
other SFGR might be serologically classiﬁed as
Rocky Mountain spotted fever (RMSF), and
perhaps result in misleading surveillance data.
Indeed, cases reported as RMSF have been
increasing in the United States in recent years.
Longitudinal studies with molecular assays
should be conducted in states where both RMSF
and A. americanum are prevalent to determine the
agent(s) infecting humans.
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